Form 4 for GEHC GE HealthCare
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0001628280-24-037701 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-19 | 2024-08-15 | GEHC | Rackliffe Philip | CEO, Ultrasound, IGT | A - Grant | $0.00 | +2,051 | 15.2K | +16% | $0 |
| D | 2024-08-19 | 2024-08-15 | GEHC | Rackliffe Philip | CEO, Ultrasound, IGT | A - Grant | $0.00 | +6,203 | 6,203 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-08-15 | A | A | 2,051 | $0.00 | 15,168 | D | — | — | (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-08-15 | A | A | 6,203 | $0.00 | 6,203 | D | $85.30 · — to 2034-08-15 | 6,203 Common Stock, par value $0.01 per share | (F3) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. |